AMP and cAMP

When the steady state level of cAMP rises, the AMP:ATP ratio in a cell also increases.

“In cardiomyocytes, β2-AR stimulation resulted in a reduction in ATP production but was accompanied by a rise in its precursor, AMP … The AMP/ATP ratio was enhanced …, which subsequently led to the activation of AMP-activated kinase (AMPK)….Lietal2010(JPhysiol).

This activates AMP kinase, which phosphorylates TSC2 and RAPTOR, a subcomplex of mTORC1, and de-activates mTORC1. mTORC1 is a protein complex that is activated by nutrients and growth factors, and it is of importance in neurodegeneration. Together with PDK1, it activates S6K1, which stimulates protein synthesis by the ribosomal protein S6. S6K1 and mTORC1 are caught in a positive feedback loop.

In other words we have a complex integration of signals that converge on the ribosome in order to influence protein synthesis by sensing energy levels in the cell. Basically, AMPK decreases protein synthesis (mTORc1).

Under optimal physiological conditions, the AMP-to-ATP ratio is maintained at a level of
0.01 (*)

(*) Hardie DG and Hawley SA. AMP-activated protein kinase: the energy
charge hypothesis revisited. Bioessays 23: 1112–1119, 2001..

And here is something entirely different: sensing ph-levels.

“Intracellular acidification, another stimulator of in vivo
cAMP synthesis, but not glucose, caused an increase in
the GTP/GDP ratio on the Ras proteins.” (RollandFetal2002)

So there is a lot that is very interesting about cAMPs connection to cellular state sensing, and mediating between cellular state and protein synthesis.

Non-modifiable synapses

Technical papers sometimes make a distinction between modifiable and non-modifiable synapses. Results on NMDA-NR2A vs. NMDA-NR2B receptors show that a NR2B receptor is required for LTP (learning), and a synapse which contains only NMDA-NR2A and AMPA glutamatergic receptors is not modifiable (except maybe for some LTD).

http://www.ncbi.nlm.nih.gov/pubmed/20164351

“Thus, for LTP induction, the physical presence of NR2B and its cytoplasmic tail are more important than the activation of NR2B–NMDARs, suggesting an essential function of NR2B as a mediator of protein interactions independent of its channel contribution. In contrast, the presence of NR2A is not essential for LTP, and, in fact, the cytoplasmic tail of NR2A seems to inhibit the induction of LTP.”

“The apparent contradiction can be explained by the fact that NR2B, in addition to forming part of a ligand-gated channel, also has a long cytoplasmic tail that binds (directly or indirectly) to a variety of postsynaptic signaling molecules.”

“Our data cannot distinguish whether these collaborating NR2A and NR2B subunits are in the same (triheteromeric) NMDAR complex or in different NMDARs (NR2A–NMDARs and NR2B–NMDARs) that lie near each other.”

“We hypothesize that the NR2A subunit also has a dual function. On one hand, it acts as a channel that facilitates LTP by conducting calcium. On the other hand, it acts as a scaffold that presumably recruits a protein to the synapse that inhibits LTP. Such a protein could act by antagonizing the activation of LTP signaling pathways [e.g., synaptic Ras-GTPase-activating protein (Kim et al., 2005)] or by stimulating the LTD signaling pathways [such as Rap and p38 mitogen-activated protein kinase) (Thomas and Huganir, 2004; Zhu et al., 2005; Li et al., 2006)].”

“Consistent with this idea, changes in plasticity in the visual cortex are correlated with a change in the NR2A/NR2B ratio. Light deprivation lowers the threshold of induction for LTP and is associated with a decrease in synaptic NR2A.”

It is hard to prove a negative, a non-modifiable synapse.  Since NR2B-containing receptors often occur in extrasynaptic positions, stimulation protocols may also recruit them to the synapse.  Triheteromeric receptor complexes do occur, but they may be less common. Also, the role of the NR2D and NR2C subunits, which may also bind to NR1, and which may help in creating Nr2A-type only synapses, is less clear.

Nonetheless it may be justified to make a distinction between “hard-to-modify” synapses and easily modifiable synapses.

This is entirely different from the “silent synapses”, which, because they contain no AMPA receptors, do not contribute (much) to fast signal transmission, but which may be recruited to full synapses, because they do contain NMDA-Nr2B receptors.

Homeostatic Regulation – LDL Receptors

A recent news story

http://www.nytimes.com/2013/02/04/business/medicines-co-licenses-rights-to-cholesterol-drug.html?_r=0

covered the development of drugs targeting PCSK9, a “pro-protein” that decreases the density of LDL receptors (e.g. in the liver). The interesting part for the computational biologist is the regulation of LDL receptors: The density of LDL receptors depends on the amount of LDL available in the bloodstream. With more LDL, their density increases. Another way to increase LDLR density are statins (drugs). However, statins also activate PCSK9. And PCSK9 acts to decrease LDL. In other words, it looks as if we have a classic homeostatic regulation, and by interfering with it at one point, we may activate processes that counteract the wanted drug effect. If we add PCSK9 inhibitors now (by monoclonal antibodies, or as in this case by miRNA interference), we believe we may have a more radical effect on keeping LDLR active. In any case, it tells us that we need to understand a system that we interfere with.